Labcorp Holdings Inc. (LH) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, Labcorp reported revenue of $13.95B, up 7.2% from $13.01B the year before. Net income was $876.5M (a 6.3% net margin), or $10.46 per diluted share. Gross margin was 28.8% and operating margin was 9.9%. Operating activities generated $1.64B of cash, leaving $1.21B of free cash flow. At fiscal year end, Labcorp held $18.39B in total assets against $9.76B in total liabilities, including $532.3M of cash and equivalents.
Open the full interactive Labcorp financials → Quarterly statements, key ratios, valuation history and price charts.
Labcorp Key Stats
| Share Price | $313.64 |
|---|---|
| Market Cap | $25.72B |
| P/E Ratio | 30.0 |
| Dividend Yield | 0.93% |
| Revenue YoY Growth | +7.2% |
| 52-Week Range | $244.17 – $338.61 |
| Shares Outstanding | 81.7 million (basic, 2026 Q2) |
Labcorp Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $13.98B | $16.12B | $14.88B | $12.16B | $13.01B | $13.95B |
| Gross Profit | $4.95B | $5.62B | $4.39B | $3.36B | $3.62B | $4.01B |
| Operating Income | $2.45B | $3.26B | $1.77B | $725.6M | $1.09B | $1.38B |
| Pre-Tax Income | $2.22B | $3.12B | $1.58B | $606.5M | $958.4M | $1.11B |
| Income Tax | $662.1M | $747.1M | $302.0M | $188.5M | $212.4M | $229.8M |
| Net Income | $1.56B | $2.38B | $1.28B | $418.0M | $746.0M | $876.5M |
| Diluted EPS | $15.88 | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |
Labcorp Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $3.56B | $3.52B | $3.54B | $3.73B |
| Net Income | $261.1M | $164.7M | $277.8M | $298.7M |
| Diluted EPS | $3.12 | $1.97 | $3.35 | $3.64 |
Labcorp Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.32B | $1.47B | $430.0M | $536.8M | $1.52B | $532.3M |
| Current Assets | $5.13B | $5.33B | $4.62B | $3.77B | $4.81B | $4.02B |
| Total Assets | $20.07B | $20.39B | $20.16B | $16.73B | $18.38B | $18.39B |
| Current Liabilities | $3.08B | $2.78B | $3.08B | $3.23B | $3.33B | $2.82B |
| Total Long-Term Debt | $5.42B | $5.42B | $5.04B | $4.05B | $5.33B | $5.58B |
| Total Liabilities | $10.69B | $10.09B | $10.04B | $8.83B | $10.31B | $9.76B |
| Shareholders' Equity | $9.36B | $10.27B | $10.10B | $7.88B | $8.05B | $8.62B |
Labcorp Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $2.14B | $3.11B | $1.96B | $1.33B | $1.59B | $1.64B |
| Cash From Investing | -$643.2M | -$884.6M | -$1.65B | -$1.17B | -$1.37B | -$1.19B |
| Cash From Financing | -$517.4M | -$2.07B | -$1.32B | -$59.3M | $779.9M | -$1.46B |
| Free Cash Flow | $1.75B | $2.65B | $1.47B | $874.1M | $1.10B | $1.21B |
| Dividends Paid | — | — | — | — | $243.1M | $240.7M |
Figures from Labcorp's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Labcorp financials page for every line item.
Labcorp Company Profile
| Ticker | LH |
|---|---|
| Exchange | NYSE |
| Industry | Medical Laboratories (Services) |
| Headquarters | Burlington, North Carolina |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000920148 |
Frequently Asked Questions
What was Labcorp's revenue in fiscal 2025?
Labcorp (LH) reported revenue of $13.95B for fiscal 2025.
What is Labcorp's annual revenue history?
Labcorp's annual revenue by fiscal year: 2020: $13.98B; 2021: $16.12B; 2022: $14.88B; 2023: $12.16B; 2024: $13.01B; 2025: $13.95B.
What was Labcorp's net income in fiscal 2025?
Labcorp reported net income of $876.5M for fiscal 2025.
What was Labcorp's earnings per share (EPS) in fiscal 2025?
Labcorp's diluted EPS was $10.46 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Labcorp generate in fiscal 2025?
Labcorp generated $1.21B of free cash flow in fiscal 2025.
What was Labcorp's revenue last quarter?
In its most recent reported quarter (2026 Q2), Labcorp reported revenue of $3.73B.
How much debt does Labcorp have?
Labcorp reported $5.58B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Labcorp are outstanding?
Labcorp reported a weighted average of 81.7 million basic shares outstanding in 2026 Q2.
What is Labcorp's market cap?
Based on its latest closing price, Labcorp (LH) has a market capitalization of about $25.72B.
When does Labcorp's fiscal year end?
Labcorp's fiscal year end, as registered with the SEC, is December 31.
Where is Labcorp headquartered?
Labcorp lists its business address in Burlington, North Carolina in its SEC filings.